{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:14:06Z","timestamp":1794446046186,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800344, 81800345, and 82000372"],"award-info":[{"award-number":["81800344, 81800345, and 82000372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515111120, 2020A1515010452 and 2020A1515011095"],"award-info":[{"award-number":["2022A1515111120, 2020A1515010452 and 2020A1515011095"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\n<\/jats:title>\n                <jats:p>Epicardial adipose tissue (EAT) has been suggested to exert deleterious effects on myocardium and cardiovascular disease (CVD) consequence. We evaluated the associations of EAT thickness with adverse outcomes and its potential mediators in the community.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants without heart failure (HF) who had undergone cardiac magnetic resonance (CMR) to measure EAT thickness over the right ventricular free wall from the Framingham Heart Study were included. The correlation of EAT thickness with 85 circulating biomarkers and cardiometric parameters was assessed in linear regression models. The occurrence of HF, atrial fibrillation, coronary heart disease (CHD), and other adverse events was tracked since CMR was implemented. Their associations with EAT thickness and the mediators were evaluated using Cox regression and causal mediation analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 1554 participants, 53.0% were females. Mean age, body mass index, and EAT thickness were 63.3\u00a0years, 28.1\u00a0kg\/m<jats:sup>2<\/jats:sup>, and 9.8\u00a0mm, respectively. After fully adjusting, EAT thickness positively correlated with CRP, LEP, GDF15, MMP8, MMP9, ORM1, ANGPTL3, and SERPINE1 and negatively correlated with N-terminal pro-B-type natriuretic peptide (NT-proBNP), IGFBP1, IGFBP2, AGER, CNTN1, and MCAM. Increasing EAT thickness was associated with smaller left ventricular end-diastolic dimension, thicker left ventricular wall thickness, and worse global longitudinal strain (GLS). During a median follow-up of 12.7\u00a0years, 101 incident HF occurred. Per 1-standard deviation increment of EAT thickness was associated with a higher risk of HF (adjusted hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.19\u20131.72, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and the composite outcome consisting of myocardial infarction, ischemic stroke, HF, and death from CVD (adjusted HR [95% CI], 1.23 [1.07\u20131.40], <jats:italic>P<\/jats:italic>\u2009=\u20090.003). Mediation effect in the association between thicker EAT and higher risk of HF was observed with NT-proBNP (HR [95% CI], 0.95 [0.92\u20130.98], <jats:italic>P<\/jats:italic>\u2009=\u20090.011) and GLS (HR [95% CI], 1.04 [1.01\u20131.07], <jats:italic>P<\/jats:italic>\u2009=\u20090.032).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>EAT thickness was correlated with inflammation and fibrosis-related circulating biomarkers, cardiac concentric change, myocardial strain impairment, incident HF risk, and overall CVD risk. NT-proBNP and GLS might partially mediate the effect of thickened EAT on the risk of HF. EAT could refine the assessment of CVD risk and become a new therapeutic target of cardiometabolic diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>URL: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\">https:\/\/clinicaltrials.gov<\/jats:ext-link>. Identifier: NCT00005121.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-02836-4","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T01:02:36Z","timestamp":1680051756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain"],"prefix":"10.1186","volume":"21","author":[{"given":"Manting","family":"Choy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-9239","authenticated-orcid":false,"given":"Yuzhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"2836_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrendo.2015.58","volume":"11","author":"G Iacobellis","year":"2015","unstructured":"Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11:363\u201371.","journal-title":"Nat Rev Endocrinol"},{"key":"2836_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.116.022064","volume":"135","author":"L Zangi","year":"2017","unstructured":"Zangi L, Oliveira MS, Ye LY, Ma Q, Sultana N, Hadas Y, et al. Insulin-like growth factor 1 receptor-dependent pathway drives epicardial adipose tissue formation after myocardial injury. Circulation. 2017;135:59\u201372.","journal-title":"Circulation"},{"key":"2836_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19:593\u2013606.","journal-title":"Nat Rev Cardiol"},{"key":"2836_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12933-021-01420-5","volume":"20","author":"E Cosson","year":"2021","unstructured":"Cosson E, Nguyen MT, Rezgani I, Berkane N, Pinto S, Bihan H, et al. Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study. Cardiovasc Diabetol. 2021;20:224.","journal-title":"Cardiovasc Diabetol"},{"key":"2836_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/eurheartj\/ehm564","volume":"29","author":"AM de Vos","year":"2008","unstructured":"de Vos AM, Prokop M, Roos CJ, Meijs MFL, van der Schouw YT, Rutten A, et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J. 2008;29:777\u201383.","journal-title":"Eur Heart J"},{"key":"2836_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","volume":"12","author":"S Hao","year":"2021","unstructured":"Hao S, Sui X, Wang J, Zhang J, Pei Y, Guo L, et al. Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation. Cell Death Dis. 2021;12:848.","journal-title":"Cell Death Dis"},{"key":"2836_CR7","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10554-018-1360-y","volume":"34","author":"JD Morales-Portano","year":"2018","unstructured":"Morales-Portano JD, Peraza-Zaldivar J\u00c1, Su\u00e1rez-Cuenca JA, Aceves-Mill\u00e1n R, Amezcua-G\u00f3mez L, Ixcamparij-Rosales CH, et al. Echocardiographic measurements of epicardial adipose tissue and comparative ability to predict adverse cardiovascular outcomes in patients with coronary artery disease. Int J Cardiovasc Imaging. 2018;34:1429\u201337.","journal-title":"Int J Cardiovasc Imaging"},{"key":"2836_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijcard.2022.04.009","volume":"357","author":"AA Mahabadi","year":"2022","unstructured":"Mahabadi AA, Anapliotis V, Dykun I, Hendricks S, Al-Rashid F, L\u00fcdike P, et al. Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease. Int J Cardiol. 2022;357:140\u20135.","journal-title":"Int J Cardiol"},{"key":"2836_CR9","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ejhf.2337","volume":"23","author":"NR Pugliese","year":"2021","unstructured":"Pugliese NR, Paneni F, Mazzola M, De Biase N, Del Punta L, Gargani L, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021;23:1858\u201371.","journal-title":"Eur J Heart Fail"},{"key":"2836_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ejhf.2513","volume":"24","author":"X Jin","year":"2022","unstructured":"Jin X, Hung C-L, Tay WT, Soon D, Sim D, Sung K-T, et al. Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction. Eur J Heart Fail. 2022;24:1346\u201356.","journal-title":"Eur J Heart Fail"},{"key":"2836_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009238","volume":"15","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Manintveld OC, van Empel VPM, Willems TP, de Boer RA, et al. Epicardial adipose tissue and outcome in heart failure with mid-range and preserved ejection fraction. Circ Heart Fail. 2022;15.","journal-title":"Circ Heart Fail"},{"key":"2836_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","volume":"8","author":"TM Gorter","year":"2020","unstructured":"Gorter TM, van Woerden G, Rienstra M, Dickinson MG, Hummel YM, Voors AA, et al. Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction. JACC Heart failure. 2020;8:667\u201376.","journal-title":"JACC Heart failure"},{"key":"2836_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136:6\u201319.","journal-title":"Circulation"},{"key":"2836_CR14","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1016\/j.jacc.2021.01.059","volume":"77","author":"C Andersson","year":"2021","unstructured":"Andersson C, Nayor M, Tsao CW, Levy D, Vasan RS. Framingham Heart Study: JACC Focus Seminar, 1\/8. J Am Coll Cardiol. 2021;77:2680\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"2836_CR15","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1210\/jc.2003-030698","volume":"88","author":"G Iacobellis","year":"2003","unstructured":"Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2836_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11845-020-02339-8","volume":"190","author":"P Ga\u0107","year":"2021","unstructured":"Ga\u0107 P, Macek P, Por\u0119ba M, Kornafel-Flak O, Mazur G, Por\u0119ba R. Thickness of epicardial and pericoronary adipose tissue measured using 128-slice MSCT as predictors for risk of significant coronary artery diseases. Ir J Med Sci. 2021;190:555\u201366.","journal-title":"Ir J Med Sci"},{"key":"2836_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/oby.2007.591","volume":"15","author":"S Fl\u00fcchter","year":"2007","unstructured":"Fl\u00fcchter S, Haghi D, Dinter D, Heberlein W, K\u00fchl HP, Neff W, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring). 2007;15:870\u20138.","journal-title":"Obesity (Silver Spring)"},{"key":"2836_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003536","volume":"10","author":"JE Ho","year":"2017","unstructured":"Ho JE, McCabe EL, Wang TJ, Larson MG, Levy D, Tsao C, et al. Cardiometabolic traits and systolic mechanics in the community. Circ Heart Fail. 2017;10.","journal-title":"Circ Heart Fail"},{"key":"2836_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","volume":"8","author":"KE Koepp","year":"2020","unstructured":"Koepp KE, Obokata M, Reddy YNV, Olson TP, Borlaug BA. Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction. JACC Heart failure. 2020;8:657\u201366.","journal-title":"JACC Heart failure"},{"key":"2836_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/EDE.0000000000000651","volume":"28","author":"Y-T Huang","year":"2017","unstructured":"Huang Y-T, Yang H-I. Causal mediation analysis of survival outcome with multiple mediators. Epidemiology. 2017;28:370\u20138.","journal-title":"Epidemiology"},{"key":"2836_CR21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.hrthm.2018.06.025","volume":"15","author":"I Abe","year":"2018","unstructured":"Abe I, Teshima Y, Kondo H, Kaku H, Kira S, Ikebe Y, et al. Association of fibrotic remodeling and cytokines\/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation. Heart Rhythm. 2018;15:1717\u201327.","journal-title":"Heart Rhythm"},{"key":"2836_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tem.2014.03.012","volume":"25","author":"T Kadomatsu","year":"2014","unstructured":"Kadomatsu T, Endo M, Miyata K, Oike Y. Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab. 2014;25:245\u201354.","journal-title":"Trends Endocrinol Metab"},{"key":"2836_CR23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ejhf.1283","volume":"20","author":"G van Woerden","year":"2018","unstructured":"van Woerden G, Gorter TM, Westenbrink BD, Willems TP, van Veldhuisen DJ, Rienstra M. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction. Eur J Heart Fail. 2018;20:1559\u201366.","journal-title":"Eur J Heart Fail"},{"key":"2836_CR24","doi-asserted-by":"publisher","first-page":"E2629","DOI":"10.3390\/ijms20112629","volume":"20","author":"DM Tanase","year":"2019","unstructured":"Tanase DM, Radu S, Al Shurbaji S, Baroi GL, Florida Costea C, Turliuc MD, et al. Natriuretic peptides in heart failure with preserved left ventricular ejection fraction: from molecular evidences to clinical implications. Int J Mol Sci. 2019;20:E2629.","journal-title":"Int J Mol Sci"},{"key":"2836_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCEP.110.957241","volume":"3","author":"O Batal","year":"2010","unstructured":"Batal O, Schoenhagen P, Shao M, Ayyad AE, Van Wagoner DR, Halliburton SS, et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:230\u20136.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2836_CR26","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","volume":"57","author":"CX Wong","year":"2011","unstructured":"Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57:1745\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"2836_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/cvr\/cvv208","volume":"108","author":"B Gaborit","year":"2015","unstructured":"Gaborit B, Venteclef N, Ancel P, Pelloux V, Gariboldi V, Leprince P, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res. 2015;108:62\u201373.","journal-title":"Cardiovasc Res"},{"key":"2836_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jcmm.14758","volume":"24","author":"L Zhao","year":"2020","unstructured":"Zhao L, Guo Z, Wang P, Zheng M, Yang X, Liu Y, et al. Proteomics of epicardial adipose tissue in patients with heart failure. J Cell Mol Med. 2020;24:511\u201320.","journal-title":"J Cell Mol Med"},{"key":"2836_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/oby.21059","volume":"23","author":"EA McAninch","year":"2015","unstructured":"McAninch EA, Fonseca TL, Poggioli R, Panos AL, Salerno TA, Deng Y, et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity (Silver Spring). 2015;23:1267\u201378.","journal-title":"Obesity (Silver Spring)"},{"key":"2836_CR30","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1253\/circj.CJ-16-0047","volume":"80","author":"W-C Tam","year":"2016","unstructured":"Tam W-C, Lin Y-K, Chan W-P, Huang J-H, Hsieh M-H, Chen S-A, et al. Pericardial fat is associated with the risk of ventricular arrhythmia in Asian patients. Circ J. 2016;80:1726\u201333.","journal-title":"Circ J"},{"key":"2836_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1532-429X-12-40","volume":"12","author":"C Doesch","year":"2010","unstructured":"Doesch C, Haghi D, Fl\u00fcchter S, Suselbeck T, Schoenberg SO, Michaely H, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson. 2010;12:40.","journal-title":"J Cardiovasc Magn Reson"},{"key":"2836_CR32","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1002\/oby.20149","volume":"21","author":"C Doesch","year":"2013","unstructured":"Doesch C, Streitner F, Bellm S, Suselbeck T, Haghi D, Heggemann F, et al. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy. Obesity (Silver Spring). 2013;21:E253-261.","journal-title":"Obesity (Silver Spring)"},{"key":"2836_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ejhf.2156","volume":"23","author":"J Tromp","year":"2021","unstructured":"Tromp J, Bryant JA, Jin X, van Woerden G, Asali S, Yiying H, et al. Epicardial fat in heart failure with reduced versus preserved ejection fraction. Eur J Heart Fail. 2021;23:835\u20138.","journal-title":"Eur J Heart Fail"},{"key":"2836_CR34","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018;71:2360\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"2836_CR35","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/jcsm.12631","volume":"11","author":"P Janovska","year":"2020","unstructured":"Janovska P, Melenovsky V, Svobodova M, Havlenova T, Kratochvilova H, Haluzik M, et al. Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. J Cachexia Sarcopenia Muscle. 2020;11:1614\u201327.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2836_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cardfail.2014.06.357","volume":"20","author":"DE Lanfear","year":"2014","unstructured":"Lanfear DE, Chow S, Padhukasahasram B, Li J, Langholz D, Tang WHW, et al. Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide. J Card Fail. 2014;20:662\u20138.","journal-title":"J Card Fail"},{"key":"2836_CR37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.119.042770","volume":"141","author":"JJ Rayner","year":"2020","unstructured":"Rayner JJ, Peterzan MA, Watson WD, Clarke WT, Neubauer S, Rodgers CT, et al. Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response. Circulation. 2020;141:1152\u201363.","journal-title":"Circulation"},{"key":"2836_CR38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","volume":"22","author":"G Iacobellis","year":"2009","unstructured":"Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22:1311\u20139 quiz 1417\u20138.","journal-title":"J Am Soc Echocardiogr."},{"key":"2836_CR39","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1093\/eurheartj\/ehz713","volume":"40","author":"YNV Reddy","year":"2019","unstructured":"Reddy YNV, Obokata M, Wiley B, Koepp KE, Jorgenson CC, Egbe A, et al. The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction. Eur Heart J. 2019;40:3721\u201330.","journal-title":"Eur Heart J"},{"key":"2836_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/obr.12270","volume":"16","author":"SW Rabkin","year":"2015","unstructured":"Rabkin SW, Campbell H. Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis. Obes Rev. 2015;16:406\u201315.","journal-title":"Obes Rev"},{"key":"2836_CR41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/cvr\/cvx186","volume":"114","author":"E D\u00edaz-Rodr\u00edguez","year":"2018","unstructured":"D\u00edaz-Rodr\u00edguez E, Agra RM, Fern\u00e1ndez \u00c1L, Adrio B, Garc\u00eda-Caballero T, Gonz\u00e1lez-Juanatey JR, et al. Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability. Cardiovasc Res. 2018;114:336\u201346.","journal-title":"Cardiovasc Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02836-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02836-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02836-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T02:04:12Z","timestamp":1680055452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02836-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2836"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02836-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects in the Framingham Heart Study had signed informed consent forms. Our current study was approved by the Medical Ethical Committee of the First Affiliated Hospital, Sun Yat-sen University (Application ID: [2019]266).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}